Tag: Prescription Drugs
ASCO: Rx Strategies Promising for CLL, Non-Hodgkin’s Lymphoma
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma
ASCO: MMR Deficiency Predicts Pembrolizumab Response
Findings may help doctors better choose patients to receive pembrolizumab (Keytruda)
Greater Benefit for Early Antiretroviral Tx Initiation in HIV
NIH-funded trial results appear likely to impact global treatment guidelines
Metformin Linked With Lower Open-Angle Glaucoma Risk
Study found people with highest dose were 25 percent less likely to develop condition
Higher Risk of VTE With Newer Forms of Oral Contraceptives
Includes brands such as Yaz, Yasmin, Desogen; risk to any one user remains very low
Pre-Op β-Blockers May Work Against Heart-Healthy Patients
But those with three or four heart risk factors may benefit from getting β-blockers
Antiatherosclerotic Activity ID’d for MTX, Adalimumab in RA
Activity may be mediated by effects on lipoprotein functions, macrophage metabolism
Beloranib Safe, Efficacious for Weight Loss in Obesity
Tolerable at doses of 0.6 and 1.2 mg; more adverse events with dose of 2.4 mg
Meds Offer Slight Symptom Relief in Overactive Bladder
Small reductions in urge incontinence episodes, voids per day with daily dose of medications
Discovery Paves New Path for Opioid Production
Could benefit medicine but researchers warn of potential to create illegal drugs
